Sign in with Google. Opens in new tab
ENTITY
GC Biopharma Corp

GC Biopharma Corp (006280 KS)

101
Analysis
Health CareSouth Korea
GC Biopharma is a biopharmaceutical company headquartered in Yongin, South Korea. It manufactures household medical drugs. The Company's product includes medicines for cold and fever, nutrition, antiseptic drug, and a lip balm.
more
bearishKakao Games
18 Jun 2021 03:18

KRX BBIG Index Rebalance Preview: Worth a Look

There are lots of changes expected to the KRX BBIG indices at the September review. With a large amount of assets tracking the indices, some of the...

Logo
609 Views
Share
bullishLG Corp
27 Apr 2021 13:56

Closing the Gap: Korean Holdcos Vs. Opcos

In this insight, we highlight the closing of the pricing gaps between the major Korean holdcos and opcos, especially with the upcoming end of the...

Logo
485 Views
Share
bullishSK Bioscience
24 Feb 2021 23:47

SK Bioscience IPO - Valuation Analysis

We believe that SK Bioscience's market cap value could be about 11.5 trillion won or 149,000 won per share which would represent 129% higher than...

Logo
385 Views
Share
bearishPearl Abyss
21 Feb 2021 08:19

KRX BBIG K-NewDeal Index Rebalance: First Set of Changes Announced

The KRX has announced changes to the KRX New Deal indices that will be effective after the close of trading on 25 February. Pearl Abyss is...

Logo
577 Views
Share
bullishSK Bioscience
06 Feb 2021 18:23

SK Bioscience IPO Preview - Biggest IPO in Korea in 1Q 2021

SK Bioscience is getting ready to complete its IPO in Korea in March. SK Bioscience will be the biggest IPO in Korea so far this year in 2021. The...

Logo
549 Views
Share
x